Загрузка...
Resisting Resistance: Targeted Therapies in Lung Cancer
Drug resistance inevitably limits the efficacy of all targeted therapies including tyrosine kinase inhibitors (TKIs). Understanding the biological underpinnings of TKI resistance is key to the successful development of future therapeutic strategies. Traditionally, mechanisms of TKI resistance have b...
Сохранить в:
| Опубликовано в: : | Trends Cancer |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5091655/ https://ncbi.nlm.nih.gov/pubmed/27819059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2016.05.010 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|